Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner.

Smith EM, Proud CG.

EMBO J. 2008 Apr 9;27(7):1005-16. doi: 10.1038/emboj.2008.39. Epub 2008 Mar 13.

2.

Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin.

Lekli I, Szabo G, Juhasz B, Das S, Das M, Varga E, Szendrei L, Gesztelyi R, Varadi J, Bak I, Das DK, Tosaki A.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H859-66. Epub 2007 Dec 7.

PMID:
18065527
3.

Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice.

Kelly J, Ali Khan A, Yin J, Ferguson TA, Apte RS.

J Clin Invest. 2007 Nov;117(11):3421-6.

4.

SIRT1 controls endothelial angiogenic functions during vascular growth.

Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, Alt FW, Zeiher AM, Dimmeler S.

Genes Dev. 2007 Oct 15;21(20):2644-58.

5.

Translation regulation after taxol treatment in NIH3T3 cells involves the elongation factor (eEF)2.

Piñeiro D, González VM, Hernández-Jiménez M, Salinas M, Martín ME.

Exp Cell Res. 2007 Oct 15;313(17):3694-706. Epub 2007 Aug 1.

PMID:
17825817
6.

Sirtuins: the 'magnificent seven', function, metabolism and longevity.

Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J.

Ann Med. 2007;39(5):335-45. Review.

PMID:
17701476
7.

Resveratrol stimulates AMP kinase activity in neurons.

Dasgupta B, Milbrandt J.

Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7217-22. Epub 2007 Apr 16.

8.
9.

Beneficial effects of treatment with transglutaminase inhibitor cystamine on macrophage response in NZB/W F1 mice.

Hsu TC, Chiang SY, Huang CY, Tsay GJ, Yang CW, Huang CN, Tzang BS.

Exp Biol Med (Maywood). 2007 Feb;232(2):195-203.

PMID:
17259326
10.

Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats.

Ates O, Cayli SR, Yucel N, Altinoz E, Kocak A, Durak MA, Turkoz Y, Yologlu S.

J Clin Neurosci. 2007 Mar;14(3):256-60.

PMID:
17258134
11.
12.

Resveratrol improves health and survival of mice on a high-calorie diet.

Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA.

Nature. 2006 Nov 16;444(7117):337-42. Epub 2006 Nov 1.

13.

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group.

N Engl J Med. 2006 Oct 5;355(14):1432-44.

14.

Therapeutic potential of resveratrol: the in vivo evidence.

Baur JA, Sinclair DA.

Nat Rev Drug Discov. 2006 Jun;5(6):493-506. Epub 2006 May 26. Review.

PMID:
16732220
15.
16.

Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo.

Garvin S, Ollinger K, Dabrosin C.

Cancer Lett. 2006 Jan 8;231(1):113-22.

PMID:
16356836
17.

Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage.

Solomon JM, Pasupuleti R, Xu L, McDonagh T, Curtis R, DiStefano PS, Huber LJ.

Mol Cell Biol. 2006 Jan;26(1):28-38.

18.
19.

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

Marambaud P, Zhao H, Davies P.

J Biol Chem. 2005 Nov 11;280(45):37377-82. Epub 2005 Sep 14.

20.

Stimulation of neovascularization by the anti-angiogenic factor PEDF.

Apte RS, Barreiro RA, Duh E, Volpert O, Ferguson TA.

Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4491-7.

PMID:
15557459

Supplemental Content

Support Center